Literature DB >> 1705166

Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.

S N Markovic1, D M Murasko.   

Abstract

We have previously demonstrated that interferon (IFN) treatment of mice bearing the spontaneously metastasizing B16F10L murine melanoma on days -5 to -1 prior to surgical removal (day 0) of the primary tumor resulted in survival of greater than 50% of treated mice. The antitumor effect was correlated with an early increase of natural killer (NK) cell cytotoxicity followed by a later developing specific cytolytic T-cell response. The purpose of this study was to establish definitively the roles of NK, CD4, and CD8 cells as mediators of the antitumor/antimetastatic effects of IFN treatment by administration of anti-asialo-GM1, anti-L3T4, and/or anti-Lyt-2 antisera. Depletion of NK cells, alone or in combination with T-cells, eliminated the protective effect of IFN treatment. Depletion of both CD4 and CD8 cells, however, did not significantly alter the therapeutic effect of IFN therapy. Collectively, these data conclusively demonstrated the importance of NK cells as mediators of the IFN induced antitumor state. However, in mice depleted of CD4 cells alone, the protective effect of IFN was eliminated, in spite of the presence of intact NK cells. In vitro analysis of NK cytotoxicity on day 1 after surgery demonstrated (a) a lack of IFN induced stimulation of NK activity in CD4 depleted mice and (b) a significant increase in both baseline and IFN induced NK cytotoxicity in CD8 depleted mice. These data suggested a CD8 cell mediated inhibition of NK activity/stimulation in CD4 depleted mice, possibly responsible for the lack of response to IFN therapy in that group. These results demonstrate the importance of not only individual components of the immune system but also the interaction of these components in both the natural and IFN induced control of spontaneous B16F10L metastases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705166

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta.

Authors:  M R Young; M A Wright; M Coogan; M E Young; J Bagash
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Immunomodulatory effects of anti-CD4 antibody in host resistance against infections and tumors in human CD4 transgenic mice.

Authors:  D J Herzyk; E R Gore; R Polsky; K L Nadwodny; C C Maier; S Liu; T K Hart; A G Harmsen; P J Bugelski
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer.

Authors:  J Riemensberger; A Böhle; S Brandau
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 4.  Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy.

Authors:  M Hernberg
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

5.  Characterization of brain and bone-metastasizing clones selected from an ethylnitrosourea-induced rat mammary carcinoma.

Authors:  D G Hall; G Stoica
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

6.  The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.

Authors:  Gregory B Lesinski; Mirela Anghelina; Jason Zimmerer; Timothy Bakalakos; Brian Badgwell; Robin Parihar; Yan Hu; Brian Becknell; Gerard Abood; Abhik Ray Chaudhury; Cynthia Magro; Joan Durbin; William E Carson
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis.

Authors:  E Katsanis; M A Bausero; A C Ochoa; C M Loeffler; B R Blazar; A S Leonard; P M Anderson
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

8.  Antitumor actions of a chromone glucoside cnidimoside A isolated from Cnidium japonicum.

Authors:  Yoshiyuki Kimura; Maho Sumiyoshi; Masahiko Taniguchi; Kimiye Baba
Journal:  J Nat Med       Date:  2008-04-17       Impact factor: 2.343

9.  Determinants of differential liver-colonizing potential of variants of the MCA-38 murine colon cancer cell line.

Authors:  J J Piscatelli; S A Cohen; C S Berenson; P Lance
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

10.  Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2.

Authors:  K L Chong; L Feng; K Schappert; E Meurs; T F Donahue; J D Friesen; A G Hovanessian; B R Williams
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.